Dolby Laboratories - DLB Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $98.00
  • Forecasted Upside: 24.67%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$78.61
▼ -1.58 (-1.97%)

This chart shows the closing price for DLB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Dolby Laboratories Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DLB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DLB

Analyst Price Target is $98.00
▲ +24.67% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Dolby Laboratories in the last 3 months. The average price target is $98.00, with a high forecast of $98.00 and a low forecast of $98.00. The average price target represents a 24.67% upside from the last price of $78.61.

This chart shows the closing price for DLB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Dolby Laboratories. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/22/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/22/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/19/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/17/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/17/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/31/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$98.00Low
12/11/2023Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$98.00Low
11/17/2023Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$98.00Low
8/4/2023Rosenblatt SecuritiesBoost TargetBuy ➝ Buy$93.00 ➝ $98.00Low
4/14/2023Tigress FinancialReiterated RatingBuy$116.00Low
2/3/2023Rosenblatt SecuritiesBoost TargetBuy$85.00 ➝ $90.00Low
11/18/2022Barrington ResearchDowngradeOutperform ➝ Market PerformLow
11/7/2022Rosenblatt SecuritiesLower TargetBuy$90.00 ➝ $85.00Low
10/14/2022Tigress FinancialLower TargetBuy$128.00 ➝ $116.00Low
5/23/2022Rosenblatt SecuritiesInitiated CoverageBuy$90.00Medium
5/12/2022Barrington ResearchLower Target$115.00 ➝ $90.00Medium
11/18/2021Barrington ResearchReiterated RatingBuy$114.00Low
11/17/2021Colliers SecuritiesReiterated RatingBuyHigh
8/2/2021Barrington ResearchUpgradeMarket Perform ➝ Outperform$115.00High
2/25/2021Tigress FinancialReiterated RatingBuyLow
1/29/2021B. RileyBoost TargetNeutral$79.00 ➝ $89.00High
1/26/2021Barrington ResearchDowngradeOutperform ➝ Market PerformHigh
1/4/2021Barrington ResearchDowngradeOutperform ➝ Market PerformN/A
11/13/2020B. RileyBoost TargetNeutral$73.00 ➝ $79.00High
8/5/2020Barrington ResearchBoost TargetOutperform$70.00 ➝ $83.00Low
8/4/2020B. RileyBoost TargetNeutral$72.00 ➝ $73.00High
6/24/2020B. RileyDowngradeBuy ➝ Neutral$68.00 ➝ $72.00High
5/29/2020B. RileyReiterated RatingBuy$68.00Low
5/5/2020JPMorgan Chase & Co.Lower TargetOverweight$66.00 ➝ $65.00High
5/5/2020B. RileyLower TargetBuy$71.00 ➝ $68.00High
4/15/2020B. RileyReiterated RatingBuy$60.00 ➝ $71.00Low
3/26/2020Barrington ResearchLower TargetPositive ➝ Outperform$85.00 ➝ $70.00Medium
3/24/2020B. RileyUpgradeNeutral ➝ Buy$57.00 ➝ $60.00High
3/18/2020B. RileyLower TargetNeutral$71.00 ➝ $57.00High
3/13/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$66.00 ➝ $66.00High
3/9/2020Tigress FinancialReiterated RatingBuyHigh
1/30/2020Barrington ResearchReiterated RatingBuyLow
1/10/2020B. RileyDowngradeBuy ➝ Neutral$73.00Low
11/21/2019Barrington ResearchReiterated RatingBuy$85.00Low
11/11/2019Dougherty & CoReiterated RatingBuyMedium
11/11/2019B. RileyUpgradeNeutral ➝ Buy$73.00Medium
9/18/2019Tigress FinancialReiterated RatingBuyLow
8/2/2019William BlairReiterated RatingBuyLow
8/2/2019B. RileyUpgradeNeutral ➝ BuyHigh
8/2/2019B. RileyReiterated RatingNeutral ➝ Neutral$67.00 ➝ $73.00High
6/13/2019B. RileySet TargetHold$67.00Low
(Data available from 4/16/2019 forward)

News Sentiment Rating

1.19 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 11 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
9/19/2023
  • 13 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2023
  • 5 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/18/2023
  • 11 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2023
  • 13 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2024
  • 20 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/16/2024
  • 21 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/17/2024
  • 8 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/16/2024

Current Sentiment

  • 8 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Dolby Laboratories logo
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices. Its audio technologies also include DD, a digital audio coding technology that provides multichannel sound to applications; DD+, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; and HEVC, a digital video codec with high bandwidth efficiency for media devices. In addition, the company offers digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides 3-D glasses and kits; and various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $78.61
Low: $78.52
High: $80.65

50 Day Range

MA: $81.71
Low: $78.04
High: $84.22

52 Week Range

Now: $78.61
Low: $75.87
High: $91.01

Volume

314,200 shs

Average Volume

378,325 shs

Market Capitalization

$7.51 billion

P/E Ratio

40.73

Dividend Yield

1.50%

Beta

0.97

Frequently Asked Questions

What sell-side analysts currently cover shares of Dolby Laboratories?

The following Wall Street analysts have issued stock ratings on Dolby Laboratories in the last year: Rosenblatt Securities, StockNews.com, and TheStreet.
View the latest analyst ratings for DLB.

What is the current price target for Dolby Laboratories?

1 Wall Street analysts have set twelve-month price targets for Dolby Laboratories in the last year. Their average twelve-month price target is $98.00, suggesting a possible upside of 24.7%. Rosenblatt Securities has the highest price target set, predicting DLB will reach $98.00 in the next twelve months. Rosenblatt Securities has the lowest price target set, forecasting a price of $98.00 for Dolby Laboratories in the next year.
View the latest price targets for DLB.

What is the current consensus analyst rating for Dolby Laboratories?

Dolby Laboratories currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DLB will outperform the market and that investors should add to their positions of Dolby Laboratories.
View the latest ratings for DLB.

What other companies compete with Dolby Laboratories?

How do I contact Dolby Laboratories' investor relations team?

Dolby Laboratories' physical mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker's listed phone number is (415) 558-0200 and its investor relations email address is [email protected]. The official website for Dolby Laboratories is www.dolby.com. Learn More about contacing Dolby Laboratories investor relations.